LDHP2FS-Lactate dehydrogenase

Added to your cart

LDHP2FS-Lactate dehydrogenase

Cart subtotal: £0.00

View cart (0) Checkout

#SKU LDHP2FS

Get in touch to purchase this product

Contact our team of experts to discuss your requirements

Contact our expert team

Product Details

Lactate Dehydrogenase (LDH) is found in almost all living cells and is used by the body in the process of turning sugars into energy. LDH catalyses’ the conversion of lactate to pyruvate and back. In Clinical Chemistry Lactate Dehydrogenase has the following applications: + As an indicator enzyme with PK to measure reactions in which ADP, ATP or pyruvate are products + As an indicator enzyme in the measurement of serum GPT + As a serum control
LDHP2FS

More information

Attributes

Description

  • Associated Activity
  • PK: less than 0.01% GPT: less than 0.025% MDH: less than 0.05%
  • Lead Time
  • 12 weeks
  • Storage
  • Store desiccated at -15C or below. Allow to come
  • Shelf Life
  • 2 years
  • Manufacturer Country
  • UK
  • Source
  • Porcine heart
  • Activity
  • ≥250U/mg protein
  • EC Number
  • 1.1.1.27
  • Systematic Name
  • [S]-Lactate:NAD+ oxidoreductase
  • Unit Definition
  • That amount of enzyme causing the oxidation of one micromole of NADH per minute at 25°C and pH 7.4.
  • Form
  • PK: less than 0.01% GPT: less than 0.025% MDH: less than 0.05%

Technical Documents

Product Specification (55.91KB)

Analytical Procedures (143.79KB)

Product Information (276.98KB)

Sorry, no results found.

Enter the full lot number and hit enter.

BBI Solutions Brands

diarect.png

The acquisition of DIARECT in June 2020 and their world leading recombinant autoimmune antigen capability immediately enhances BBI’s portfolio and position as a ‘complete’ immunoassay reagent supplier. This further enhances BBI’s position as the world’s largest diagnostics components company with a market leading antigen portfolio.

mbs.png

Maine Biotechnology Services brings 27 years of knowledge, experience, process development, and project management to our customers to ensure the best possible antibodies for any application. As antibody development goals in the biotechnology and pharmaceutical industry have evolved the acquisition of MBS will help BBI further meet and exceed our customers needs.

Newsletter

Signup for our newsletter to receive the latest BBI Solutions updates and special offers in your inbox